MF
ALXN

Magnetar Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Magnetar Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,114,010
Closed -$205K – 1716
2021
Q2 		$205K Sell
1,114,010
-175,838
-14% -$30.2M 1.94% 2
2021
Q1 		$197M Buy
1,289,848
+109,195
+9% +$16.9M 1.9% 7
2020
Q4 		$184M Buy
+1,180,653
New +$152M 2.61% 6
2019
Q4 		– Sell
-118,049
Closed -$11.6M – 678
2019
Q3 		$11.6M Buy
118,049
+63,449
+116% +$7.15M 0.29% 64
2019
Q2 		$7.15M Buy
54,600
+35,600
+187% +$4.59M 0.14% 78
2019
Q1 		$2.57M Buy
19,000
+15,227
+404% +$1.89M 0.07% 89
2018
Q4 		$367K Buy
+3,773
New +$446K 0.01% 171
2017
Q4 		– Sell
-3,584
Closed -$503K – 938
2017
Q3 		$503K Buy
+3,584
New +$487K 0.01% 428
2017
Q2 		– Sell
-2,823
Closed -$342K – 1001
2017
Q1 		$342K Buy
+2,823
New +$364K ﹤0.01% 534
2016
Q4 		– Sell
-11,595
Closed -$1.42M – 431
2016
Q3 		$1.42M Buy
11,595
+2,424
+26% +$312K 0.02% 217
2016
Q2 		$1.07M Buy
+9,171
New +$1.3M 0.02% 165

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Magnetar Financial's ALXN Position: Q3 2021 in Review

Magnetar Financial sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,114,010 shares — an estimated $205K sold.

Magnetar Financial first reported a position in ALXN in Q2 2016 and held it in 11 quarters. The position peaked at $197M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Magnetar Financial reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Magnetar Financial sold 1,114,010 Alexion Pharmaceuticals shares in Q3 2021, an estimated $205K.
  • Magnetar Financial first reported a position in Alexion Pharmaceuticals in Q2 2016 and held it in 11 quarters.
  • Magnetar Financial's Alexion Pharmaceuticals position peaked at $197M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Magnetar Financial's 13F filing for Q3 2021, filed 12 Nov 2021.